Cassava Sciences | PTIE - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Abbott USD 2.13B 281M 2026-06
Amgen USD 3.83B 130M 2026-03
Biogen USD -243.8M 758.1M 2026-06
Cara Therapeutics USD -5.94M 3.55M 2025-09
Cassava Sciences USD -11.17M 2.38M 2026-03
Eisai JPY -10.31B 30.35B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Geron USD -236K 10.55M 2026-03
J&J USD 7.48B 860M 2026-06
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.75B 515M 2026-06
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.99B 340M 2026-03
Roche Holding CHF 11.46B 1.91B 2026-06